|
1
|
Chick G, Alnot JY and Silbermann-Hoffman
O: Benign solitary tumors of the peripheral nerves. Rev Chir Orthop
Reparatrice Appar Mot. 86:825–834. 2000.(In French).
|
|
2
|
Knight DM, Birch R and Pringle J: Benign
solitary schwannomas: a review of 234 cases. J Bone Joint Surg Br.
89:382–387. 2007.
|
|
3
|
Amirjamshidi A, Hashemi SM and Abbassioun
K: Schwannoma of the greater superficial petrosal nerve. J
Neurosurg. 113:1093–1098. 2010.
|
|
4
|
Ikushima K, Ueda T, Kudawara I, Nakanishi
K and Yoshikawa H: Plexiform schwannoma of the foot. Eur Radiol.
9:1653–1655. 1999.
|
|
5
|
Agarwal K, Agarwal C, Agarwal M and
Harbhajanka A: Plexiform schwannoma of scalp: a case report with
brief review of literature. Indian J Pathol Microbiol. 50:797–799.
2007.
|
|
6
|
Singson RD, Dee G and Quader MA: Case
report 265. Scalloping and destruction of pedicles of lumbar
vertebral bodies on the right side secondary to venous collaterals,
associated with thrombosis of the inferior ±vena cava. Skeletal
Radiol. 11:293–295. 1984.
|
|
7
|
Inaoka T, Takahashi K, Hanaoka H, et al:
Paravertebral neurinoma associated with aggressive intravertebral
extension. Skeletal Radiol. 30:286–289. 2001.
|
|
8
|
Singrakhia MD, Parmar H, Maheshwari M and
Fehlings M: Cervical schwannoma presenting as an expansile
vertebral body lesion: report of two cases with a technical note on
the surgical management. Surg Neurol. 66:192–196. 2006.
|
|
9
|
Nakamura Y, Wakitani S, Nakayama J,
Wakabayashi S, Horiuchi H and Takaoka K: Temporal and spatial
expression profiles of BMP receptors and noggin during
BMP-2-induced ectopic bone formation. J Bone Miner Res.
18:1854–1862. 2003.
|
|
10
|
Tylzanowski P, Mebis L and Luyten FP: The
Noggin null mouse phenotype is strain dependent and
haploinsufficiency leads to skeletal defects. Dev Dyn.
235:1599–1607. 2006.
|
|
11
|
Devlin RD, Du Z, Pereira RC, Kimble RB,
Economides AN, Jorgetti V and Canalis E: Skeletal overexpression of
noggin results in osteopenia and reduced bone formation.
Endocrinology. 144:1972–1978. 2003.
|
|
12
|
Gazzerro E, Gangji V and Canalis E: Bone
morphogenetic proteins induce the expression of noggin, which
limits their activity in cultured rat osteoblasts. J Clin Invest.
102:2106–2114. 1998.
|
|
13
|
Bachiller D, Klingensmith J, Kemp C, et
al: The organizer factors Chordin and Noggin are required for mouse
forebrain development. Nature. 403:658–661. 2000.
|
|
14
|
Krause C, Guzman A and Knaus P: Noggin.
Int J Biochem Cell Biol. 43:478–481. 2011.
|
|
15
|
Bonaguidi MA, Peng CY, McGuire T, et al:
Noggin expands neural stem cells in the adult hippocampus. J
Neurosci. 28:9194–9204. 2008.
|
|
16
|
Li W and LoTurco JJ: Noggin is a negative
regulator of neuronal differentiation in developing neocortex. Dev
Neurosci. 22:68–73. 2000.
|
|
17
|
Fletcher CDM, Unni KK and Mertens F:
Pathology and Genetics of Tumours of Soft Tissue and Bone. 4. World
Health Organisation; Lyon: 2002
|
|
18
|
Miyazono K, Kamiya Y and Morikawa M: Bone
morphogenetic protein receptors and signal transduction. J Biochem.
147:35–51. 2010.
|
|
19
|
Takayama K, Suzuki A, Manaka T, et al: RNA
interference for noggin enhances the biological activity of bone
morphogenetic proteins in vivo and in vitro. J Bone
Miner Metab. 27:402–411. 2009.
|
|
20
|
Yoshimura Y, Nomura S, Kawasaki S,
Tsutsumimoto T, Shimizu T and Takaoka K: Colocalization of noggin
and bone morphogenetic protein-4 during fracture healing. J Bone
Miner Res. 16:876–884. 2001.
|
|
21
|
Nakase T, Nomura S, Yoshikawa H, et al:
Transient and localized expression of bone morphogenetic protein 4
messenger RNA during fracture healing. J Bone Miner Res. 9:651–659.
1994.
|
|
22
|
Brunet LJ, McMahon JA, McMahon AP and
Harland RM: Noggin, cartilage morphogenesis, and joint formation in
the mammalian skeleton. Science. 280:1455–1457. 1998.
|
|
23
|
Holley SA, Neul JL, Attisano L, et al: The
Xenopus dorsalizing factor noggin ventralizes Drosophila embryos by
preventing DPP from activating its receptor. Cell. 86:607–617.
1996.
|
|
24
|
Iemura S, Yamamoto TS, Takagi C, et al:
Direct binding of follistatin to a complex of bone-morphogenetic
protein and its receptor inhibits ventral and epidermal cell fates
in early Xenopus embryo. Proc Natl Acad Sci USA. 95:9337–9342.
1998.
|
|
25
|
Zimmerman LB, De Jesús-Escobar JM and
Harland RM: The Spemann organizer signal noggin binds and
inactivates bone morphogenetic protein 4. Cell. 86:599–606.
1996.
|
|
26
|
Mikawa S and Sato K: Noggin expression in
the adult rat brain. Neuroscience. 184:38–53. 2011.
|
|
27
|
Asahara H, Kawai A, Harada Y, Senda M and
Inoue H: Spinal schwannomas: a review of 42 cases. Acta Med
Okayama. 50:25–28. 1996.
|
|
28
|
Chibbaro S, Mirone G, Makiese O, Bresson D
and George B: Dumbbell-shaped jugular foramen schwannomas: surgical
management, outcome and complications on a series of 16 patients.
Neurosurg Rev. 32:151–159. 2009.
|
|
29
|
Yokota H, Isobe K, Murakami M, Kubosawa H
and Uno T: Dumbbell-shaped nonpsammomatous malignant melanotic
schwannoma of the cervical spinal root. Spine J. 12:e14–e17.
2012.
|
|
30
|
Piek J: Giant schwannoma of the cauda
equina without neurological deficits - case report and review of
the literature. Wien Klin Wochenschr. 122:645–648. 2010.
|
|
31
|
Jankowski R, Szmeja J, Nowak S, Sokół B
and Blok T: Giant schwannoma of the lumbar spine. A case report.
Neurol Neurochir Pol. 44:91–95. 2010.
|
